SCHEMBL5776767

SCHEMBL5776767

Clc1nc(Cl)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 4/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CDC7 O00311 2/20 0.42
POLB P06746 2/20 0.41
PKM P14618 2/20 0.41
RAB9A P51151 2/20 0.41
MAPT P10636 2/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
XDH P47989 2/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5771482 0.87 KDM4E (0.47) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5774543 0.84 ADORA1 (0.48) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5773970 0.81 ADORA1 (0.49) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5773135 0.80 SMN1; SMN2 (0.55) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5772105 0.80 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5774041 0.80 ADORA3 (0.51) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5773513 0.78 ADORA3 (0.53) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5776325 0.77 ADORA1 (0.54) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5775603 0.73 ADORA3 (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5775897 0.71 MEN1 (0.45) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed